Ainscough, Alexander J.
Smith, Timothy J.
Haensel, Maike
Rhodes, Christopher J.
Fellows, Adam http://orcid.org/0000-0002-9975-3795
Whitwell, Harry J.
Vasilaki, Eleni
Gray, Kelly
Freeman, Adrian
Howard, Luke S. http://orcid.org/0000-0003-2822-210X
Wharton, John http://orcid.org/0000-0001-8110-2575
Dunmore, Benjamin
Upton, Paul D. http://orcid.org/0000-0003-2716-4921
Wilkins, Martin R. http://orcid.org/0000-0003-3926-1171
Edel, Joshua B. http://orcid.org/0000-0001-5870-8659
Wojciak-Stothard, Beata http://orcid.org/0000-0002-6607-7372
Funding for this research was provided by:
British Heart Foundation (FS/17/64/33476, PG/19/19/34286, RE/18/4/34215)
Article History
Received: 4 May 2022
Accepted: 25 October 2022
First Online: 7 November 2022
Competing interests
: Ambrisentan and AZD5153 used in this study were provided by Astra Zeneca.